Search

Song, Kunhua, Zhong Wang, and Kedryn K Baskin. 2022. “Editorial: Metabolic Regulation in Cardiovascular Homeostasis and Disease.”. Frontiers in Cardiovascular Medicine 9: 995207.

Knight, Walter E, Yingqiong Cao, Phoebe Dillon, and Kunhua Song. 2021. “A Simple Protocol to Produce Mature Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.”. STAR Protocols 2 (4): 100912.

Song, Kunhua, Johannes Backs, John McAnally, Xiaoxia Qi, Robert D Gerard, James A Richardson, Joseph A Hill, Rhonda Bassel-Duby, and Eric N Olson. 2006. “The Transcriptional Coactivator CAMTA2 Stimulates Cardiac Growth by Opposing Class II Histone Deacetylases.”. Cell 125 (3): 453-66.

Zhang, Xiao-Shi, Kun-Hua Song, Hai-Qiang Mai, Wei-Hua Jia, Bing-Jian Feng, Jian-Chuan Xia, Ru-Hua Zhang, et al. 2002. “The 30-Bp Deletion Variant: A Polymorphism of Latent Membrane Protein 1 Prevalent in Endemic and Non-Endemic Areas of Nasopharyngeal Carcinomas in China.”. Cancer Letters 176 (1): 65-73.

Doiron, JE., Z. Li, TE. Sharp, KB. LaPenna, K. Koul, AJ. Malek, SJ. Shah, et al. 2024. “Early Renal Denervation Attenuates Cardiorenal Dysfunction in Heart Failure With Preserved Ejection Fraction”. Journal of the American Heart Association.

Li, Z., H. Xia, TE. Sharp, KB. LaPenna, JW. Elrod, JW. Calvert, FN. Salloumn, et al. 2022. “Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure”. Circulation Research.

Doiron, JE., H. Xio, X. Yu, AR. Nevins, KB. LaPenna, TE. Sharp, TT. Goodchild, et al. 2024. “Adjunctive Therapy With an Oral H2S Donor Provides Additional Therapeutic Benefit Beyond SGLT2 Inhibition in Cardiometabolic HFpEF”. British Journal of Pharmacology.

Hauser, RA, L Zeitlin, S Fisher, and R D’Souza. 2021. “Duration of Benefit Per Dose: Carbidopa-Levodopa Immediate Release Vs. Extended Release Capsules (Rytary®). Parkinsonism Relat Disord 2021;82:133-137.”. Parkonsonism Relat Disord.

Patel, AT, MF Lew, K Dashtipour, S Isaacson, RA Hauser, W Ondo, P Maisonobe, S Wietek, B Rubin, and A Brashear. 2021. “Sustained Functional Benefits After a Single Set of Injections With AbobotulinumtoxinA Using a 2-ML Injection Volume in Adults With Cervical Dystonia: 12-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study.”. ECollection.